Carol Roberts - Hard To Sec

Insider

Carol Roberts is Sec of Hard to Treat
Address Room EF, 12F, Shenzhen, China, 518040
Phone86 755 8272 0498
Webhttps://www.mellowhope.com

Similar Executives

Showing other executives

INSIDER Age

Reinhard KanderaHookipa Pharma
55
Marine PopoffHookipa Pharma
N/A
Sunil MDSana Biotechnology
54
Michael QuigleyArcus Biosciences
38
Murray MDX4 Pharmaceuticals
63
Nicole LambertArcus Biosciences
46
Cindy HayashiCaribou Biosciences
N/A
YuWaye MDFate Therapeutics
N/A
Mr MSKaryopharm Therapeutics
N/A
Steven KannerCaribou Biosciences
65
Shanna PeekSana Biotechnology
N/A
Mary DiBiaseX4 Pharmaceuticals
63
Arthur TaverasX4 Pharmaceuticals
60
Edward IIIFate Therapeutics
48
Renato SkerljX4 Pharmaceuticals
N/A
Jason MBACaribou Biosciences
56
Linda HigginsArcus Biosciences
N/A
Richard MDX4 Pharmaceuticals
61
Jonathan YinglingArcus Biosciences
55
Carolyn TangArcus Biosciences
41
RPh RPhKaryopharm Therapeutics
55
Hard to Treat Diseases Inc. manufactures, supplies, and exports biopharmaceuticals and vaccines in China and internationally. Hard to Treat Diseases Inc. was founded in 2009 and is based in Shenzhen, China. Hard To operates under Biotechnology classification in the United States and is traded on OTC Exchange. Hard to Treat (HTDS) is traded on OTCCE Exchange in USA and employs 4 people. Hard To is listed under Biotechnology category by Fama And French industry classification.

Hard to Treat Leadership Team

Elected by the shareholders, the Hard To's board of directors comprises two types of representatives: Hard To inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hard. The board's role is to monitor Hard To's management team and ensure that shareholders' interests are well served. Hard To's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hard To's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shimin Yuan, Chief Officer
Carol Roberts, Sec
Sanja Pekovic, Chief Scientist
Ivana Gadjanski, Communication Director

Hard Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hard To a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Hard Stock Analysis

When running Hard To's price analysis, check to measure Hard To's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hard To is operating at the current time. Most of Hard To's value examination focuses on studying past and present price action to predict the probability of Hard To's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hard To's price. Additionally, you may evaluate how the addition of Hard To to your portfolios can decrease your overall portfolio volatility.